在骨髓增生异常综合征的预后模型中加入年龄和合并症的（不）便利性。 - Suppr

(In)convenience of adding age and comorbidities to prognostic models in myelodysplastic syndromes.

作者信息

Calvo Xavier, Florensa Lourdes, Arenillas Leonor

机构信息

Laboratorio de Citología Hematológica. Servicio de Patología, GRETNHE, IMIM Hospital del Mar Research Institute, Barcelona, Spain.

出版信息

Leukemia. 2018 May;32(5):1264-1266. doi: 10.1038/s41375-018-0064-6. Epub 2018 Feb 22.

DOI:10.1038/s41375-018-0064-6

PMID:29483710

Abstract

摘要

相似文献

(In)convenience of adding age and comorbidities to prognostic models in myelodysplastic syndromes.

Leukemia. 2018 May;32(5):1264-1266. doi: 10.1038/s41375-018-0064-6. Epub 2018 Feb 22.

Age and comorbidities deeply impact on clinical outcome of patients with myelodysplastic syndromes.

Leuk Res. 2015 Aug;39(8):846-52. doi: 10.1016/j.leukres.2015.05.007. Epub 2015 Jun 22.

The myelodysplastic syndrome-comorbidity index provides additional prognostic information on patients stratified according to the revised international prognostic scoring system.

Haematologica. 2014 Mar;99(3):e31-2. doi: 10.3324/haematol.2013.101055. Epub 2014 Jan 24.

MDS-Comorbidity Index using register data has prognostic impact in Swedish MDS patients.

Leuk Res. 2023 Nov;134:107386. doi: 10.1016/j.leukres.2023.107386. Epub 2023 Sep 7.

Myelodysplastic syndromes: An analysis of non-hematological prognostic factors and its relationship to age.

J Geriatr Oncol. 2020 Jan;11(1):125-127. doi: 10.1016/j.jgo.2019.06.021. Epub 2019 Jul 11.

[Impact analysis of comorbidities on prognosis of myelodysplastic syndromes patients].

Zhonghua Xue Ye Xue Za Zhi. 2012 Jul;33(7):574-6.

Allogeneic hematopoietic stem-cell transplantation for myelodysplastic syndrome.

Hematology Am Soc Hematol Educ Program. 2010;2010:325-9. doi: 10.1182/asheducation-2010.1.325.

The impact of age on the diagnosis and therapy of myelodysplastic syndromes: results from a retrospective multicenter analysis in Germany.

Eur J Haematol. 2013 Dec;91(6):473-82. doi: 10.1111/ejh.12196. Epub 2013 Sep 18.

The incorporation of comorbidities in the prognostication of patients with lower-risk myelodysplastic syndrome.

Leuk Lymphoma. 2017 Aug;58(8):1893-1902. doi: 10.1080/10428194.2016.1267350. Epub 2016 Dec 12.

The evaluation of the outcome in myelodysplastic patients by using non-cytogenetic prognostic scores.

J Med Life. 2014 Sep 15;7(3):335-8. Epub 2014 Sep 25.

引用本文的文献

Impact of age on the cumulative risk of transformation in patients with chronic myelomonocytic leukaemia.

Eur J Haematol. 2021 Aug;107(2):265-274. doi: 10.1111/ejh.13647. Epub 2021 Jun 1.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

(In)convenience of adding age and comorbidities to prognostic models in myelodysplastic syndromes.

作者信息

Calvo Xavier, Florensa Lourdes, Arenillas Leonor

机构信息

Laboratorio de Citología Hematológica. Servicio de Patología, GRETNHE, IMIM Hospital del Mar Research Institute, Barcelona, Spain.

出版信息

Leukemia. 2018 May;32(5):1264-1266. doi: 10.1038/s41375-018-0064-6. Epub 2018 Feb 22.

DOI:10.1038/s41375-018-0064-6

PMID:29483710

Abstract

摘要

相似文献

(In)convenience of adding age and comorbidities to prognostic models in myelodysplastic syndromes.

Leukemia. 2018 May;32(5):1264-1266. doi: 10.1038/s41375-018-0064-6. Epub 2018 Feb 22.

Age and comorbidities deeply impact on clinical outcome of patients with myelodysplastic syndromes.

Leuk Res. 2015 Aug;39(8):846-52. doi: 10.1016/j.leukres.2015.05.007. Epub 2015 Jun 22.

The myelodysplastic syndrome-comorbidity index provides additional prognostic information on patients stratified according to the revised international prognostic scoring system.

Haematologica. 2014 Mar;99(3):e31-2. doi: 10.3324/haematol.2013.101055. Epub 2014 Jan 24.

MDS-Comorbidity Index using register data has prognostic impact in Swedish MDS patients.

Leuk Res. 2023 Nov;134:107386. doi: 10.1016/j.leukres.2023.107386. Epub 2023 Sep 7.

Myelodysplastic syndromes: An analysis of non-hematological prognostic factors and its relationship to age.

J Geriatr Oncol. 2020 Jan;11(1):125-127. doi: 10.1016/j.jgo.2019.06.021. Epub 2019 Jul 11.

[Impact analysis of comorbidities on prognosis of myelodysplastic syndromes patients].

Zhonghua Xue Ye Xue Za Zhi. 2012 Jul;33(7):574-6.

Allogeneic hematopoietic stem-cell transplantation for myelodysplastic syndrome.

Hematology Am Soc Hematol Educ Program. 2010;2010:325-9. doi: 10.1182/asheducation-2010.1.325.

The impact of age on the diagnosis and therapy of myelodysplastic syndromes: results from a retrospective multicenter analysis in Germany.

Eur J Haematol. 2013 Dec;91(6):473-82. doi: 10.1111/ejh.12196. Epub 2013 Sep 18.

The incorporation of comorbidities in the prognostication of patients with lower-risk myelodysplastic syndrome.

Leuk Lymphoma. 2017 Aug;58(8):1893-1902. doi: 10.1080/10428194.2016.1267350. Epub 2016 Dec 12.

The evaluation of the outcome in myelodysplastic patients by using non-cytogenetic prognostic scores.

J Med Life. 2014 Sep 15;7(3):335-8. Epub 2014 Sep 25.

引用本文的文献

Impact of age on the cumulative risk of transformation in patients with chronic myelomonocytic leukaemia.

Eur J Haematol. 2021 Aug;107(2):265-274. doi: 10.1111/ejh.13647. Epub 2021 Jun 1.

(In)convenience of adding age and comorbidities to prognostic models in myelodysplastic syndromes.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

(In)convenience of adding age and comorbidities to prognostic models in myelodysplastic syndromes.

作者信息

机构信息

出版信息

相似文献

引用本文的文献